Funding was led by B Capital group, and existing investors participated in the round, according to a news release. Widya Mulyasasmita, PhD, a senior investor at B Capital Group, will join Carlsmed’s board as an observer.
Carlsmed’s Aprevo implants are patient-specific and designed for spinal fusions. The device was granted two CMS payments in 2021.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
